ImmunityBio
IBRX
IBRX
163 hedge funds and large institutions have $357M invested in ImmunityBio in 2024 Q1 according to their latest regulatory filings, with 34 funds opening new positions, 49 increasing their positions, 43 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
163
Holders Change
+17
Holders Change %
+11.64%
% of All Funds
2.36%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
34
Increased
49
Reduced
43
Closed
16
Calls
$26.4M
Puts
$24.4M
Net Calls
+$2.08M
Net Calls Change
-$7.31M
Top Buyers
| 1 |
State Street
Boston,
Massachusetts
|
$76.2M |
| 2 |
PA
Perceptive Advisors
New York
|
$5.65M |
| 3 |
UBS Group
Zurich,
Switzerland
|
$4.97M |
| 4 |
Citigroup
New York
|
$6.06M |
| 5 |
SSWM
Sheets Smith Wealth Management
Winston-Salem,
North Carolina
|
$5.08M |
Top Sellers
| 1 |
Morgan Stanley
New York
|
$3.35M |
| 2 |
Jane Street
New York
|
$1.65M |
| 3 |
D.E. Shaw & Co
New York
|
$1.27M |
| 4 |
BlackRock
New York
|
$55.7M |
| 5 |
NYLIM
New York Life Investment Management
New York
|
$0 |
